Status
Conditions
Treatments
About
Familial hypercholesterolemia (FH) is a common disease. The genetic background to FH is not yet fully understood. In the present prospective cohort study we aim to study the association between different clinical characteristics, gene mutations and prognosis.
Full description
In this prospective observational cohort study of patients with high clinical suspicion of familial hypercholesterolemia (FH) we aim to study the association between different clinical characteristics, gene mutations and prognosis.
The included patients will undergo physical examination and extended blood sampling. DNA will be extracted and used for both whole genome sequencing and investigation of both known- , unknown- and suspected mutations associated with FH.
The patients will be followed in for 15 years in the Swedish patients registry and the Swedish cause of death registry.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
150 participants in 1 patient group
Loading...
Central trial contact
Anna M Nordenskjöld, MD, PhD; Anna Green, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal